Zoom shares drop 16% after Pfizer's coronavirus vaccine announcement

Zoom, the popular video conferencing app with nearly 300 million daily users, witnessed a drop in share prices after the pharmaceutical giant, Pfizer announced that its Covid-19 vaccine has proven to be 90% effective in building immunity against the virus. Zoom has been witnessing a massive surge in daily users from 10 million daily users in December, 2019 to 200 million daily users in March, 2020.

https://www.businessinsider.in/stock-market/news/zoom-tumbles-16-as-pfizers-vaccine-success-drags-on-work-from-home-stocks/articleshow/79132092.cmsZoom, the popular video conferencing app with nearly 300 million daily users, witnessed a drop in share prices after the pharmaceutical giant, Pfizer announced that its Covid-19 vaccine has proven to be 90% effective in building immunity against the virus.

Zoom has been witnessing a massive surge in daily users from 10 million daily users in December, 2019 to 200 million daily users in March, 2020.

Sign Up for NextBigWhat Newsletter

Daily.

You May Also Like